Mark A. Prygocki, Sr. has served as a director and chairman of the Revance audit committee since May 2014. Mr. Prygocki currently serves on the Board of Directors of Clarus Therapeutics, Inc. as well as Chairman of its audit committee. Mr. Prygocki is a pharmaceutical industry leader with over 20 years of experience, specializing in corporate strategy and operational efficiency. He worked at Medicis Pharmaceutical Corporation for more than 20 years and served as President from July 2010 to December 2012. Prior to that, Mr. Prygocki held several senior‐level positions at Medicis, including Chief Operating Officer, Executive Vice President, and Chief Financial Officer and Treasurer. Mr. Prygocki’s previous experience includes work at Citigroup, an investment banking firm, in the regulatory reporting division. Prior to that, Mr. Prygocki spent several years in the audit department of Ernst & Young, LLP. He holds a B.S. in accounting from Pace Uiversity and is certified by the Arizona State Board of Accountancy and the New York Society of CPAs. Mr. Prygocki serves on the board of Whispering Hope Ranch Foundation, a non-profit organization that assists children with special needs.